In vivo evidence for dysregulation of mGluR5 as a biomarker of suicidal ideation
Open accessThe DOI matches its Crossref record; 14 of the 14 references it cites were found in a registry or an index.
Abstract
Significance: Posttraumatic stress disorder (PTSD) is an important risk factor for suicidal ideation, attempts, and death by suicide. Understanding of the biology underlying suicidality in PTSD is limited. In this study, we used positron emission tomography to evaluate the metabotropic glutamate receptor type 5 (mGluR5) as a potential treatment target and biomarker of suicidal ideation in individuals with PTSD and major depressive disorder (MDD). We found higher availability of mGluR5 in individuals with PTSD relative to healthy control and MDD groups. Furthermore, higher mGluR5 availability was associated with scan-day suicidal ideation among individuals with PTSD, but not MDD. Findings identify mGluR5 as a biomarker for intervention and potentially suicide risk management in PTSD.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Blevins, C. A., Weathers, F. W., Davis, M. T., Witte, T. K., & Domino, J. L. (2015) · Journal of Traumatic Stress · doi:10.1002/jts.22059 · Cited by 5,233
Self-citationStetler, C., & Miller, G. E. (2011) · Psychosomatic Medicine · doi:10.1097/psy.0b013e31820ad12b · Cited by 1,123 · cited 1×
“By contrast, there is significant evidence of HPA axis hyperactivity in MDD, including heightened basal cortisol relative to comparison controls (29).”
BackgroundRessler, K. J., Rothbaum, B. O., Tannenbaum, L., Anderson, P., Graap, K., Zimand, E., Hodges, L., & Davis, M. (2004) · Archives of General Psychiatry · doi:10.1001/archpsyc.61.11.1136 · Cited by 1,063 · cited 1×
“mGluR5 activation moderates the function of N-methyl-D-aspartate glutamate receptors (NMDA-R) (8–10), an ionotropic glutamate receptor critical to synaptic plasticity (11, 12) and emotional learning (13, 14).”
BackgroundSelf-citationRisk factors for suicidality in Europe: Results from the ESEMED study
Bernal, M., Haro, J. M., Bernert, S., Brugha, T., de Graaf, R., Bruffaerts, R., Lépine, J. P., de Girolamo, G., Vilagut, G., Gasquet, I., et al. (2007) · Journal of Affective Disorders · doi:10.1016/j.jad.2006.09.018 · Cited by 565
Low urinary cortisol excretion in Holocaust survivors with posttraumatic stress disorder
(1995) · American Journal of Psychiatry · doi:10.1176/ajp.152.7.982 · Cited by 499
Roy, A., Gorodetsky, E., Yuan, Q., Goldman, D., & Enoch, M.-A. (2010) · Neuropsychopharmacology · doi:10.1038/npp.2009.236 · Cited by 282 · cited 2×
“Notably, HPA axis hypoactivity, as observed in PTSD, has also been associated with suicidal behavior; studies suggest reduced glucocorticoid signaling in PTSD, and down-regulation of FKBP5 has been associated with risk for suicide attempt (28, 31, 32) and death by suicide (33, 34).”
BackgroundDeschwanden, A., Karolewicz, B., Feyissa, A. M., Treyer, V., Ametamey, S. M., Johayem, A., Burger, C., Auberson, Y. P., Sovago, J., Stockmeier, C. A., et al. (2011) · American Journal of Psychiatry · doi:10.1176/appi.ajp.2011.09111607 · Cited by 278
Anxiety disorders and suicidality in the National Comorbidity Survey-Replication
Cougle, J. R., Keough, M. E., Riccardi, C. J., & Sachs-Ericsson, N. (2009) · Journal of Psychiatric Research · doi:10.1016/j.jpsychires.2008.12.004 · Cited by 253 · cited 1×
“P stress disorder (PTSD) is an important risk factor for suicidal ideation, suicidal attempts, and death by suicide (1, 2).”
BackgroundSex differences in glutamate receptor gene expression in major depression and suicide
Gray, A. L., Hyde, T. M., Deep-Soboslay, A., Kleinman, J. E., & Sodhi, M. S. (2015) · Molecular Psychiatry · doi:10.1038/mp.2015.91 · Cited by 250
Potential Psychiatric Applications of Metabotropic Glutamate Receptor Agonists and Antagonists
Krystal, J. H., Mathew, S. J., DʼSouza, D. C., Garakani, A., Gunduz-Bruce, H., & Charney, D. S. (2010) · CNS Drugs · doi:10.2165/11533230-000000000-00000 · Cited by 180
Self-citationNeuropathology of suicide: Recent findings and future directions
Lutz, P.-E., Mechawar, N., & Turecki, G. (2017) · Molecular Psychiatry · doi:10.1038/mp.2017.141 · Cited by 158
Brent, D., Melhem, N., Ferrell, R., Emslie, G., Wagner, K. D., Ryan, N., Vitiello, B., Birmaher, B., Mayes, T., Zelazny, J., et al. (2010) · American Journal of Psychiatry · doi:10.1176/appi.ajp.2009.09040576 · Cited by 138 · cited 1×
“Notably, HPA axis hypoactivity, as observed in PTSD, has also been associated with suicidal behavior; studies suggest reduced glucocorticoid signaling in PTSD, and down-regulation of FKBP5 has been associated with risk for suicide attempt (28, 31, 32) and death by suicide (33, 34).”
BackgroundHomer1/mGluR5 Activity Moderates Vulnerability to Chronic Social Stress
Wagner, K. V., Hartmann, J., Labermaier, C., Häusl, A. S., Zhao, G., Harbich, D., Schmid, B., Wang, X.-D., Santarelli, S., Kohl, C., et al. (2015) · Neuropsychopharmacology · doi:10.1038/npp.2014.308 · Cited by 67 · cited 1×
“However, we hypothesize a combination of depression in hypothalamic-pituitary-adrenal (HPA) axis function (22–24) and up-regulation in scaffolding proteins that traffic and lock mGluR5 at the membrane (25, 26) might contribute to dysregulation in mGluR5 availability in PTSD suicidality.”
BackgroundGenome-wide association studies of suicidal behaviors: a review
Sokolowski, M., Wasserman, J., & Wasserman, D. (2014) · European Neuropsychopharmacology · doi:10.1016/j.euroneuro.2014.08.006 · Cited by 48
Cited by
Holmes, S. E., Asch, R. H., Davis, M. T., DellaGioia, N., Pashankar, N., Gallezot, J.-D., Nabulsi, N., Matuskey, D., Sanacora, G., Carson, R. E., et al. (2023) · Biological Psychiatry · doi:10.1016/j.biopsych.2022.10.018 · Cited by 27
Self-citationMeasuring the effects of ketamine on mGluR5 using [ 18 F]FPEB and PET
Holmes, S. E., Gallezot, J.-D., Davis, M. T., DellaGioia, N., Matuskey, D., Nabulsi, N., Krystal, J. H., Javitch, J. A., DeLorenzo, C., Carson, R. E., et al. (2020) · Journal of Cerebral Blood Flow & Metabolism · doi:10.1177/0271678x19886316 · Cited by 24
Self-citationRugo‐Cook, K. F., Kerig, P. K., Crowell, S. E., & Bryan, C. J. (2021) · Journal of Traumatic Stress · doi:10.1002/jts.22782 · Cited by 25
The metabotropic glutamate receptor 5 as a biomarker for psychiatric disorders
(2023) · International Review of Neurobiology · doi:10.1016/bs.irn.2022.10.007 · Cited by 8
Self-citation
Metadata
- Authors
- Davis, M. T., Hillmer, A., Holmes, S. E., Pietrzak, R. H., DellaGioia, N., Nabulsi, N., Matuskey, D., Angarita, G. A., Carson, R. E., Krystal, J. H., & Esterlis, I.
- Venue
- Proceedings of the National Academy of Sciences
- Published
- 2019-05-13
- Volume
- 116
- Issue
- 23
- Pages
- 11490-11495
- ISSN
- 0027-8424 (ISSN-L)
- 1091-6490
- OpenAlex
- W2945545318
- Cited by
- 50
- References
- 14
- FWCI
- 6.27
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.